Acacia Research (NASDAQ:ACTG) Stock Price Passes Above 200-Day Moving Average – Should You Sell?

Acacia Research Corporation (NASDAQ:ACTGGet Free Report)’s share price passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $4.03 and traded as high as $5.01. Acacia Research shares last traded at $4.83, with a volume of 346,072 shares.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on ACTG. Weiss Ratings raised Acacia Research from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, March 13th. Wall Street Zen downgraded Acacia Research from a “buy” rating to a “hold” rating in a research note on Saturday, March 14th. Finally, Craig Hallum increased their price objective on Acacia Research from $5.00 to $6.00 and gave the stock a “buy” rating in a research note on Thursday, March 12th. One research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $6.00.

Read Our Latest Report on ACTG

Acacia Research Trading Down 2.8%

The company has a quick ratio of 8.64, a current ratio of 9.18 and a debt-to-equity ratio of 0.10. The stock has a market capitalization of $465.95 million, a PE ratio of 21.00 and a beta of 0.44. The firm has a 50 day moving average price of $4.65 and a 200 day moving average price of $4.03.

Acacia Research (NASDAQ:ACTGGet Free Report) last issued its quarterly earnings results on Wednesday, March 11th. The business services provider reported $0.03 EPS for the quarter, beating analysts’ consensus estimates of ($0.14) by $0.17. The company had revenue of $50.13 million during the quarter, compared to the consensus estimate of $38.00 million. Acacia Research had a return on equity of 4.11% and a net margin of 7.60%.

Institutional Trading of Acacia Research

Institutional investors and hedge funds have recently modified their holdings of the business. AQR Capital Management LLC purchased a new stake in shares of Acacia Research during the first quarter valued at approximately $35,000. Pekin Hardy Strauss Inc. purchased a new stake in shares of Acacia Research during the fourth quarter valued at approximately $37,000. Zions Bancorporation National Association UT purchased a new stake in shares of Acacia Research during the fourth quarter valued at approximately $38,000. Sather Financial Group Inc purchased a new stake in shares of Acacia Research during the third quarter valued at approximately $48,000. Finally, Occudo Quantitative Strategies LP purchased a new stake in shares of Acacia Research during the fourth quarter valued at approximately $49,000. 86.69% of the stock is owned by hedge funds and other institutional investors.

About Acacia Research

(Get Free Report)

Acacia Research Corporation is a publicly traded patent licensing company based in New York City. The firm specializes in acquiring patented technologies through a network of wholly owned subsidiaries and seeking licensing agreements or settlements with companies that utilize those technologies. Since its founding in 1993, Acacia has built a business model centered on identifying innovative inventions and monetizing them through patent enforcement and strategic partnerships.

The company’s activities span a broad range of technology sectors, including life sciences, medical devices, software, telecommunications and consumer electronics.

See Also

Receive News & Ratings for Acacia Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acacia Research and related companies with MarketBeat.com's FREE daily email newsletter.